Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, June 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Shareholders claim Vertex Pharmaceuticals inflated its share price by failing to disclose adverse information about its experimental hepatitis C drug, VX-950 (telaprevir), in Boston Federal Court.

Shareholders accuse directors of Candela Corp. or wasting corporate assets and breaching fiduciary duties, in Middlesex County Court, Woburn, Mass.

Shareholders accuse Familymedsgroup of wasting more than $80 million in corporate assets, in Hartford Superior Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...